In-vitro Fertilization (IVF) Market Size

In-vitro Fertilization Market Size

In-vitro Fertilization Market size was valued at USD 20.2 billion in 2023 and is set to register growth at a 5.7% CAGR between 2024 and 2032. The growth of the market is primarily driven by increasing infertility rates.

To get key market trends

  Download Free Sample

According to the World Health Organization (WHO), about 186 million individuals worldwide live with infertility. Additionally, conditions such as polycystic ovary syndrome (PCOS) and endometriosis, which affect 1 in 10 women globally, are contributing to the rising demand for IVF.

Another significant growth driver is delayed parenthood and an aging population. According to CDC data, the birth rate among women aged 40 to 44 years rose by 4% in 2022. Fertility naturally declines with age, particularly after 35, leading to increased reliance on Assisted Reproductive Technology (ART), including IVF, for conception. The American Society for Reproductive Medicine reports that women over 35 account for more than 40% of ART cycles. Thus, as the age of pregnancy increases, the demand for procedures such as IVF will escalate, driving market growth.

In-vitro fertilization is a medical procedure used to assist with conception by fertilizing an egg in a laboratory setting—outside the human body—and then transferring the resultant embryo into the woman's uterus. It is one of the most common and effective forms of Assisted Reproductive Technology (ART), used to treat various infertility issues, including ovulation disorders, blocked or damaged fallopian tubes, and male infertility.